Captor Therapeutics SA (DUS:60Q) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adam Łukojć | Chief Financial Officer · Since at least Nov 5, 2026 |
| Anna Pawluk | Chief Operating Officer · Since at least Nov 5, 2026 |
| Michał Walczak | Chief Executive Officer, Chief Scientific Officer · Since at least Nov 5, 2026 |